go back

Brexucabtagene Autoleucel (Tecartus)

Wisconsin rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $645,654 · 10th–90th $380,189$645,6540%50%10th$645,654Professionalmedian $977,237 · 10th–90th $59$977,2370%50%10th$977,237$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Medica
Setting
Facility
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23
Medica
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
Molina
Setting
Professional
Modifier
Global
Typical Low
$58.88
Median
$58.88
Typical High
$58.88
Quartz
Setting
Facility
Modifier
Global
Typical Low
$380,189.40
Median
$380,189.40
Typical High
$645,654.23
Quartz
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22